Discontinued — last reported Q3 '23
Current Liabilities
Derivative liabilities
Pfizer Derivative liabilities remained flat by 0.0% to $1.10B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.9%, from $910.00M to $1.10B.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2018
Last reportedQ3 2023
How to read this metric
Changes indicate shifts in market valuations and the bank's hedging effectiveness or trading exposure.
Detailed definition
Derivative liabilities represent the fair value of derivative contracts that are in a net loss position for the bank. Th...
Peer comparison
Standard metric for banks with significant global markets or hedging operations.
Metric ID:
fin_derivative_liabilitiesHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $618.00M | $357.00M | $568.00M | $362.00M | $595.00M | $763.00M | $854.00M | $941.00M | $770.00M | $775.00M | $910.00M | $646.00M | $1.10B | $1.10B |
| QoQ Change | — | -42.2% | +59.1% | -36.3% | +64.4% | +28.2% | +11.9% | +10.2% | -18.2% | +0.6% | +17.4% | -29.0% | +70.3% | +0.0% |
| YoY Change | — | — | — | -41.4% | +66.7% | +34.3% | +135.9% | +58.2% | +0.9% | -9.3% | -3.3% | -16.1% | +41.9% | +20.9% |
Range$357.00M – $1.10B
CAGR+19.4%
Avg YoY Growth+26.2%
Median YoY Growth+20.9%
Current Streak2 quarters growth
Derivative liabilities at Other Companies
Frequently Asked Questions
- What is Pfizer's derivative liabilities?
- Pfizer (PFE) reported derivative liabilities of $1.10B in Q3 2025.
- How has Pfizer's derivative liabilities changed year-over-year?
- Pfizer's derivative liabilities increased by 20.9% year-over-year, from $910.00M to $1.10B.
- What does derivative liabilities mean?
- The current market value of derivative contracts where the bank owes money to counterparties.